BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33349427)

  • 21. [Testicular Cancer: Diagnostics, Therapy and Follow Up].
    Kälin M; Mauti L; Pless M
    Praxis (Bern 1994); 2016 May; 105(11):643-8. PubMed ID: 27223417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term follow up experience of comprehensive treatment of testicular mixed germ cell tumors].
    Ye JF; Wang B; Ma LL; Zhao L; Wang GL; Hong K
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):648-651. PubMed ID: 28816282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Testicular germ-cell tumour: diagnosis and treatment].
    Houlgatte A; Bauduceau O
    Ann Urol (Paris); 2005 Oct; 39(5):159-69. PubMed ID: 16370168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist.
    Hammerich KH; Schroeck FR; West D; Moul JW
    Oncology (Williston Park); 2010 Jul; 24(8):757-60. PubMed ID: 20718257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
    Cohn-Cedermark G; Stahl O; Tandstad T;
    Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEOM clinical guidelines for the management of germ cell testicular cancer (2016).
    Aparicio J; Terrasa J; Durán I; Germà-Lluch JR; Gironés R; González-Billalabeitia E; Gumà J; Maroto P; Pinto A; García-Del-Muro X
    Clin Transl Oncol; 2016 Dec; 18(12):1187-1196. PubMed ID: 27815687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S; Albers P; Heidenreich A
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
    Li R; Li H
    BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ Cell Testicular Tumors-Contemporary Diagnosis, Staging and Management of Localized and Advanced disease.
    Goldberg H; Klaassen Z; Chandrasekar T; Fleshner N; Hamilton RJ; Jewett MAS
    Urology; 2019 Mar; 125():8-19. PubMed ID: 30597167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment strategy for stage I testicular germ cell tumor].
    Nakai Y; Nagahara A; Uemura M; Takayama H; Nonomura N
    Hinyokika Kiyo; 2012 Dec; 58(12):715-20. PubMed ID: 23328172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Part I: testicular cancer--management of early disease.
    Jones RH; Vasey PA
    Lancet Oncol; 2003 Dec; 4(12):730-7. PubMed ID: 14662429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metachronous testicular seminoma with an interval of 14 years from the first nonseminomatous testicular tumor: a case report].
    Kawasaki M; Satoh Y; Nakashima K; Nishimura K; Kaneko A; Udoh K; Fujiyama C; Uozumi J
    Nihon Hinyokika Gakkai Zasshi; 2009 Jan; 100(1):16-21. PubMed ID: 19198225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
    Hashizume A; Mizuno N; Kawai M; Kishida T
    Hinyokika Kiyo; 2016 Jul; 62(7):383-7. PubMed ID: 27569358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.